GSK-1904529A

GSK-1904529A
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-G7541.1 1 mg -

3 - 8 business days*

156.00€
LKT-G7541.5 5 mg -

3 - 8 business days*

548.00€
LKT-G7541.25 25 mg -

3 - 8 business days*

1,805.00€
 
GSK-1904529A is an inhibitor of the insulin receptor (InsR) and IGF-1R that exhibits anticancer... more
Product information "GSK-1904529A"
GSK-1904529A is an inhibitor of the insulin receptor (InsR) and IGF-1R that exhibits anticancer chemotherapeutic activity. In cellular and animal models of multiple myeloma and Ewing's sarcoma, GSK-1904529A induces cell cycle arrest and inhibits cell proliferation and tumor growth.
Keywords: GSK1904529A
Supplier: LKT Laboratories
Supplier-Nr: G7541

Properties

Application: InsR / IGF-1R inhibitor
MW: 851.96 D
Purity: >98%
Format: Solid

Database Information

CAS : 1089283-49-7| Matching products
KEGG ID : K04527 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H302, H312, H332, H410
P Phrases: P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P312, P322, P330, P363, P391, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GSK-1904529A"
Write a review
or to review a product.
Viewed